XTL BIOPHARMACEUTICALS LTD.

XTL BIOPHARMACEUTICALS LTD.

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. Its lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. XTL Biopharmaceuticals Ltd. has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel.

XTL Biopharmaceuticals Ltd._logo

Industry:
Company

Founded:
1993

Address:
5 Badner Street, Ramat Gan, Israel Zipcode 5218102

Country:
Israel

Phone:
972 3 611 6600

Market Cap:
57.59M
Total Assets:
6.5M
Total Cash:
3.63M

Parent organization: Yeda Research & Development Co Ltd

Website Url:
http://www.xtlbio.com


Key Executives
Name Title Pay Year Born
Mr. Shlomo Spokone Shalev CEO & Director N/A 1962(58 years old)
Mr. Itay Weinstein Chief Financial Officer N/A 1971(49 years old)
Mr. Ronen Kantor Adv Company Sec. N/A N/A



Financial & Stock
Exchange Tel Aviv. Currency in ILA. Market state CLOSED
According to XTL Biopharmaceuticals Ltd.'s financial reports the company's revenue in 2020 were 0 an decrease(NAN%) over the years 2019 revenue that were of 0. In 2020 the company's total earnings were -782k while total earnings in 2019 were -1.35M(-21.8%).
Company's stock symbol is XTLB.TA. Lastest price : 11.20. Total volume :910.78k Click reload if you want to check the lastest price on market!!!


Site Inspections: http://www.xtlbio.com

  • Host name: mail.cloudhost.co.il
  • IP address: 192.117.187.254
  • Location: Tel Aviv Israel
  • Latitude: 32.0678
  • Longitude: 34.7647
  • Timezone: Asia/Jerusalem

Loading ...
Loading ...


More informations about "XTL Biopharmaceuticals Ltd." on Search Engine

XTLbio | treatment of unmet clinical needs

Xtlbio.com XTL Biopharmaceuticals Ltd. focuses on the acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. XTL is a public company, traded on the NASDAQ (NASDAQ:XTLB) and the Tel-Aviv Stock Exchange (TASE:XTLB.TA)

XTLbio | treatment of unmet clinical needs

Xtlbio.com The XTLbio pipeline is generated by systematically identifying, validating and in …

XTLbio | treatment of unmet clinical needs

Xtlbio.com XTL’s ADRs (1:20 ratio) are publicly traded on the NASDAQ and its shares are traded on …

XTLbio | treatment of unmet clinical needs

Xtlbio.com Menu. About Us; Pipeline; News; Investors; Contact Us; News

XTLbio | treatment of unmet clinical needs

Xtlbio.com Mr. Weinstein holds a B.A. in economics and accounting from the Tel Aviv University, …

XTLbio | treatment of unmet clinical needs

Xtlbio.com XTL Biopharmaceuticals Ltd. 5 Badner St., P.O.Box 8241 Ramat Gan 5218102 Israel …

XTLbio | treatment of unmet clinical needs

Xtlbio.com XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTL) focuses on the acquisition and …

XTLbio | treatment of unmet clinical needs

Xtlbio.com hCDR1 is a novel compound, working via a novel mechanism of action, for the …

XTLbio | treatment of unmet clinical needs

Xtlbio.com XTL is continually looking for late stage products to in-license or acquire. In …

XTL Biopharmaceuticals Ltd. (XTLB) Company Profile & Facts

Finance.yahoo.com XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of …

XTL Biopharmaceuticals Ltd. (XTLB) Stock Price, News

Finance.yahoo.com Find the latest XTL Biopharmaceuticals Ltd. (XTLB) stock quote, history, news and other vital information to help you with your stock trading and investing.

XTLB Stock Price | XTL Biopharmaceuticals Ltd. ADR Stock

Marketwatch.com Apr 09, 2021 · XTL Biopharmaceuticals Ltd. ADR XTL Biopharmaceuticals Ltd. focuses on the acquisition and development of proprietary products and late-stage pharmaceutical product candidates for the treatment of...

XTLB:NASDAQ CM Stock Quote - XTL Biopharmaceuticals Ltd

Bloomberg.com XTL Biopharmaceuticals, Ltd. operates as a biopharmaceutical company. The Company focuses on the acquisition and development of proprietary products and late-stage pharmaceutical product candidates...

XTLB XTL Biopharmaceuticals Ltd. — Stock Price and

Stocktwits.com Apr 09, 2021 · XTL Biopharmaceuticals Ltd. OTC Updated Apr 9, 2021 8:00 PM XTLB 3.28 0.08 (2.30%). 1,108

XTLB Stock: XTL Biopharmaceuticals Is Rocketing - CNA Finance

Cnafinance.com Mar 05, 2021 · XTL Biopharmaceuticals is a clinical-stage biotech company that’s working on the development of novel therapeutics for indications with large unmet needs. In particular, XTLB …

Xtl Biopharmaceuticals Ltd. - XTLB - Stock Price Today - Zacks

Zacks.com Apr 09, 2021 · XTL Biopharmaceuticals Ltd. is a biopharmaceutical company developing drugs against hepatitis.

XTL Biopharmaceuticals Ltd. | LinkedIn

Linkedin.com XTL Biopharmaceuticals Ltd. | 84 followers on LinkedIn. XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB, TASE:XTLB.TA) is a clinical-stage biotech company focused on the development of pharmaceutical ...

XTL Biopharmaceuticals Ltd. (XTLB) – The 87.5% Upside

Newsrts.com Mar 08, 2021 · XTL Biopharmaceuticals Ltd. (XTLB) Top Institutional Holders 4 institutions hold shares in XTL Biopharmaceuticals Ltd. (XTLB), with 1.03M shares held by insiders accounting for 19.95% while institutional investors hold 10.84% of the company’s shares. The shares outstanding are 5.14M, and float is at 5.14M with Short Float at 0.55%.

XTL Biopharmaceuticals Ltd. American Depositary Shares

Nasdaq.com XTL Biopharmaceuticals Ltd. American Depositary Shares (XTLB)

Why XTL Biopharmaceuticals Ltd. (XTLB) is soaring high in

Parktelegraph.com Mar 05, 2021 · XTL Biopharmaceuticals Ltd is a pharmaceutical company focused on the development of pharmaceutical products to treat autoimmune diseases. XTL Biopharmaceuticals Ltd. was founded in 1993 and its headquarters is in Ramat Gan, Israel. The company changes its name from Xenograft Technologies Ltd. to XTL Biopharmaceuticals Ltd in 1995.

XTL Biopharmaceuticals Ltd. (XTLB) Stock Message Board

Investorshub.advfn.com Mar 05, 2021 · XTL Biopharmaceuticals Ltd. is a biopharmaceutical company engaged in the acquisition and development of pharmaceutical products for the treatment of …

XTLB | XTL Biopharmaceuticals Ltd. ADR Annual Income

Marketwatch.com May 17, 2020 · XTL Biopharmaceuticals Ltd. ADR Annual stock financials by MarketWatch. View the latest XTLB financial statements, income statements and financial ratios.

XTLB XTL Biopharmaceuticals Ltd. Stock Quote

Finviz.com XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. Its lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome.

XTL Biopharmaceuticals Ltd ADR (XTLB) Quote - XNAS

Morningstar.com XTL Biopharmaceuticals Ltd is engaged in the field of healthcare. It is a pharmaceutical manufacturer, with a focus on acquisition and development of late-stage pharmaceutical product candidates...

XTLB | XTL Biopharmaceuticals Ltd. ADR Profile | MarketWatch

Marketwatch.com XTL Biopharmaceuticals Ltd. focuses on the acquisition and development of proprietary products and late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. The ...

12-month price target for XTL Biopharmaceuticals Ltd

Marketingsentinel.com Mar 05, 2021 · XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) trade information. Upright in the green today for gaining 50.19%, in the last five days XTLB remained trading in the green while hitting it’s week-highest on Friday, Mar 05 when the stock touched $6.11-3 …

XTL Biopharmaceuticals Ltd. (XTLB) Stock Price Today

Seekingalpha.com XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases.

Read this Insightful XTL Biopharmaceuticals Ltd. (XTLB)

Baxterreport.com Feb 09, 2021 · XTL Biopharmaceuticals Ltd. (XTLB) saw an uptrend of 21.64% in the recent trading with $3.71 being its most recent. The current price level -11.03% lower than the highest price of $4.17 marked by the stock while trading over the past 52-weeks, whereas it is 493.60% higher than the lowest price of $0.63 the company dropped to over past 52-weeks.

XTLB - XTL Biopharmaceuticals Ltd. • BioPharmCatalyst

Biopharmcatalyst.com Yoqneam, Israel, July 01, 2020 (GLOBE NEWSWIRE) -- Seedo Corp. (OTC:SEDO) ("Seedo") announced its shareholders have elected a new Board of Directors.The new Board brings decades of executive corporate, business and financial experience to now move the Company forward.

XTL Biopharmaceuticals Ltd. (XTLB) upgraded Issued by Wall

Newsheater.com Mar 05, 2021 · XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) went up by 45.02% from its latest closing price compared to the recent 1-year high of $4.17. The company’s stock price has collected -4.93% of loss in the last five trading sessions. Get the hottest …

XTL Biopharmaceuticals Ltd. - Crunchbase Company Profile

Crunchbase.com XTL Biopharmaceuticals Ltd is a clinical-stage biotech company focused on the development of pharmaceutical products for the treatment of autoimmune diseases including lupus. The Company’s lead drug candidate, hCDR1, is a world-class clinical asset for …

XTL Biopharmaceuticals Ltd. (XTLB) Stock Historical Prices

Finance.yahoo.com Discover historical prices for XTLB stock on Yahoo Finance. View daily, weekly or monthly format back to when XTL Biopharmaceuticals Ltd. stock was issued.

XTLB | XTL Biopharmaceuticals Ltd. ADR Company Profile

Wsj.com XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its pipeline includes hCDR1 and Erythropoietin.

XTLB | XTL Biopharmaceuticals Ltd. ADR Stock Price & News

Wsj.com View the latest XTL Biopharmaceuticals Ltd. ADR (XTLB) stock price, news, historical charts, analyst ratings and financial information from WSJ.

XTLB: XTL Biopharmaceuticals Ltd. - Earnings News

Zacks.com XTLB: XTL Biopharmaceuticals Ltd. - Earnings Announcements. Stay up to date with lastest Earnings Announcements for XTL Biopharmaceuticals Ltd. from Zacks Investment Research

XTL Biopharmaceuticals Ltd - Company Profile and News

Bloomberg.com XTL Biopharmaceuticals, Ltd. operates as a biopharmaceutical company. The Company focuses on the acquisition and development of proprietary products and late-stage pharmaceutical product ...

Here is why XTL Biopharmaceuticals Ltd. (XTLB) stock

Investchronicle.com Mar 05, 2021 · XTL Biopharmaceuticals Ltd. (XTLB) full year performance was 106.43%. Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, XTL Biopharmaceuticals Ltd. shares are logging -4.56% during the 52-week period from high price, and ...

XTL Biopharmaceuticals Ltd. - TASE

Mayafiles.tase.co.il XTL Biopharmaceuticals Ltd. | Purchase price allocation – InterCure 3 Details regarding the valuation specialist BDO was founded by the partners of BDO Certified Public Accountants. BDO is part of the international BDO network, provides a full range of business services required for national and international businesses in any sector.

Xtl Biopharmaceuticals Ltd Earnings & Revenue 2011-2021

Wallstreetzen.com As of Q1 2021, Xtl Biopharmaceuticals Ltd's earnings has grown null year over year. Xtl Biopharmaceuticals Ltd's earnings in the past year totalled -$782.00 thousand.

XTL Biopharmaceuticals Ltd. ADR Stock Price (XTLB) | Barron's

Barrons.com May 29, 2020 · View today's stock price, news and analysis for XTL Biopharmaceuticals Ltd. ADR (XTLB). Barron's also provides information on historical …

Why is XTL Biopharmaceuticals Ltd. (XTLB) up 155.10% from

Investchronicle.com Mar 08, 2021 · XTL Biopharmaceuticals Ltd. (XTLB) full year performance was 155.10%. Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, XTL Biopharmaceuticals Ltd. shares are logging -44.84% during the 52-week period from high price, and ...

XTL Biopharmaceuticals Ltd. (XTLB) Latest Stock News

Finance.yahoo.com Get the latest XTL Biopharmaceuticals Ltd. (XTLB) stock news and headlines to help you in your trading and investing decisions.

XTL BIOPHARMACEUTICALS LTD (Form: SC 13D/A, Received: 12)

Marketwatch.com xtl biopharmaceuticals ltd. (name of issuer) american depository receipts, each representing ten ordinary shares, par value nis 0.02 (title of class of securities) 98386d109 (cusip number) ...

Market Analysts see XTL Biopharmaceuticals Ltd. [XTLB

Dbtnews.com Mar 08, 2021 · XTL Biopharmaceuticals Ltd. [XTLB] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 16.46. With this latest performance, XTLB shares gained by 25.42% in over the last four-week period, additionally plugging by 107.18% over the last 6 months – not to mention a rise of 155.10% in the past year ...

XTL Biopharmaceuticals Ltd. (XTLB) Environment, Social and

Finance.yahoo.com See XTL Biopharmaceuticals Ltd. (XTLB) Environment, Social and Governance Ratings to help you in your stock buying decisions.

XTLB: XTL Biopharmaceuticals Ltd. - Financial Overview

Zacks.com View XTLB: XTL Biopharmaceuticals Ltd.investment & stock information. Get the latest XTLB: XTL Biopharmaceuticals Ltd. detailed stock quotes, stock data, Real-Time ECN, charts, stats and more..

content.edgar-online.com

Content.edgar-online.com 5 Badner St. Ramat Gan, Israel, 5218102 . Tel: (972) 3-6116600 (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offic

XTLB | XTL Biopharmaceuticals Ltd. ADR Financial

Wsj.com XTL Biopharmaceuticals Ltd. ADR balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View XTLB financial statements in full.

XTLB - XTL Biopharmaceuticals Ltd. - American Depositary

Benzinga.com Jan 01, 2010 · XTL Biopharmaceuticals Ltd. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Listing Requirements PRNewswire Dec 06, 2017 XTL Biopharmaceuticals Reports Third Quarter 2017 Financial ...

XTL Biopharmaceuticals Ltd. American Depositary Shares

Nasdaq.com XTL Biopharmaceuticals Ltd. American Depositary Shares (XTLB) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.

XTLB.O - X T L Biopharmaceuticals Ltd (ADR) Profile | Reuters

Reuters.com XTL Biopharmaceuticals Ltd., incorporated on March 9, 1993, is a biopharmaceutical company. The Company is engaged in the acquisition and development of pharmaceutical drugs for the treatment of ...

XTLB: XTL Biopharmaceuticals Ltd. - Detailed Estimates

Zacks.com XTLB: XTL Biopharmaceuticals Ltd. Detailed Estimate. Get the latest Detailed Estimate from Zacks Investment Research.